追蹤
Mahmoud Sheha
Mahmoud Sheha
Professor of Medicinal Chemistry, Assiut University
在 aun.edu.eg 的電子郵件地址已通過驗證 - 首頁
標題
引用次數
引用次數
年份
Synthesis of di-and tripeptide analogues containing α-ketoamide as a new core structure for inhibition of HIV-1 protease
MM Sheha, NM Mahfouz, HY Hassan, AF Youssef, T Mimoto, Y Kiso
European journal of medicinal chemistry 35 (10), 887-894, 2000
792000
Biological and metabolic study of naproxen–propyphenazone mutual prodrug
M Sheha, A Khedr, H Elsherief
European journal of pharmaceutical sciences 17 (3), 121-130, 2002
572002
Quantitative thin-layer chromatographic method of analysis of azithromycin in pure and capsule forms
A Khedr, M Sheha
Journal of chromatographic science 41 (1), 10-16, 2003
362003
Enhanced delivery of γ-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy
G Quéléver, P Kachidian, C Melon, C Garino, Y Laras, N Pietrancosta, ...
Organic & Biomolecular Chemistry 3 (13), 2450-2457, 2005
342005
1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for specific brain delivery I: synthesis and estimation of oxidation kinetics using multivariate calibration …
S Mahmoud, T Aboul‐Fadl, M Sheha, H Farag, AMI Mouhamed
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003
312003
Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors
NG Mohamed, MM Sheha, HY Hassan, LJM Abdel-Hafez, FA Omar
Bioorganic Chemistry 81, 599-611, 2018
302018
Brain delivery of HIV protease inhibitors
MM Sheha, NA El‐Koussi, HH Farag
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003
302003
New carrier for specific delivery of drugs to the brain
M Sheha, A Al-Tayeb, H El-Sherief, H Farag
Bioorganic & medicinal chemistry 11 (8), 1865-1872, 2003
292003
Substituted thiazolamide coupled to a redox delivery system: a new γ-secretase inhibitor with enhanced pharmacokinetic profile
Y Laras, G Quéléver, C Garino, N Pietrancosta, M Sheha, F Bihel, ...
Organic & Biomolecular Chemistry 3 (4), 612-618, 2005
272005
Stress degradation studies on betahistine and development of a validated stability-indicating assay method
A Khedr, M Sheha
Journal of Chromatography B 869 (1-2), 111-117, 2008
252008
Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery
M Sheha
Archives of pharmacal research 35, 523-530, 2012
242012
Sensitive determination of trimetazidine in spiked human plasma by HPLC with fluorescence detection after pre-column derivatization with 9-fluorenylmethyl chloroformate
A Khedr, MM Sheha, IA Darwish
Journal of Chromatography B 856 (1-2), 337-342, 2007
222007
Synthesis, Antibacterial Activity and Molecular Docking of Substituted Naphthyridines as Potential DNA Gyrase Inhibitors
FA Omar, M Abelrasoul, MM Sheha, HY Hassan, YM Ibrahiem
ChemistrySelect 3 (9), 2604-2612, 2018
162018
1, 2‐dihydroisoquinoline‐N‐acetic acid derivatives as new carriers for brain‐specific delivery II: delivery of phenethylamine as model drug
S Mahmoud, M Sheha, T Aboul‐Fadl, H Farag
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2003
122003
Thiazolamide–Ascorbic Acid Conjugate: a γ-Secretase Inhibitor with Enhanced Blood–Brain Barrier Permeation
Y Laras, M Sheha, N Pietrancosta, JL Kraus
Australian journal of chemistry 60 (2), 128-132, 2007
92007
Design, synthesis, and cytotoxicity evaluation of novel griseofulvin analogues with improved water solubility
AK Hamdy, MM Sheha, AA Abdel-Hafez, SA Shouman
International Journal of Medicinal Chemistry 2017 (1), 7386125, 2017
72017
Design, synthesis, and modelling study of new 1, 2, 3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors
MTE Maghraby, OIA Salem, BGM Youssif, MM Sheha
Chemical Biology & Drug Design 101 (3), 749-759, 2023
62023
New 1, 2, 3-triazole/1, 2, 4-triazole hybrids as aromatase inhibitors: Design, synthesis, and apoptotic antiproliferative activity
MTE Maghraby, T Mazyad Almutairi, S Bräse, OIA Salem, BGM Youssif, ...
Molecules 28 (20), 7092, 2023
52023
Amantadine amides prodrugs as hepatic delivery systems to enhance its activity against HCV
T Aboul-Fadl, MM Sheha, AS El-Azab, HA Abdel-Aziz
Dig J Nanomater Biostruct 6, 1675-1683, 2011
42011
Synthesis, analgesic and anti-inflammatory activities of 4-oxo-4-(4-(pyrimidin-2-yl) piperazin-1-yl) butanoic acid derivatives
HM Abdel-Rahman, MM Sheha
MCAIJ 1, 7-13, 2005
22005
系統目前無法執行作業,請稍後再試。
文章 1–20